• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不含药物的壳聚糖包被聚(异丁基氰基丙烯酸酯)纳米颗粒对阴道毛滴虫具有活性,且对猪阴道黏膜无毒。

Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa.

作者信息

Pradines Bénédicte, Bories Christian, Vauthier Christine, Ponchel Gilles, Loiseau Philippe M, Bouchemal Kawthar

机构信息

Institut Galien Paris Sud, UMR CNRS 8612, Faculté de Pharmacie, Univ Paris-Sud, Châtenay-Malabry, France.

出版信息

Pharm Res. 2015 Apr;32(4):1229-36. doi: 10.1007/s11095-014-1528-7. Epub 2014 Oct 16.

DOI:10.1007/s11095-014-1528-7
PMID:25319099
Abstract

PURPOSE

The present work reports a non-conventional therapeutic strategy based on the use of vaginally-applied formulations for the treatment of trichomoniasis due to Trichomonas vaginalis without adding a drug.

METHODS

The formulations were based on a thermosensitive pluronic® F127 hydrogel containing mucoadhesive poly(isobutylcyanoacrylate) nanoparticles coated with a mixture of chitosan and thiolated chitosan (75/25 wt%). The nanoparticles were obtained by anionic emulsion polymerization of isobutylcyanoacrylate. The anti-T. vaginalis activity of the formulations was evaluated in vitro.

RESULTS

Chitosan-coated nanoparticles showed a strong anti-T. vaginalis activity at 100 μg/mL independently on the proportion of thiolated chitosan. No anti-T. vaginalis activity was reported neither with chitosan-uncoated poly(isobutylcyanoacrylate) nanoparticles nor with chitosan used as a solution. These results suggest that the anti-T. vaginalis activity was related to poly(isobutylcyanoacrylate) nanoparticles but only when they are coated with chitosan. Histological analysis of ex vivo pig vaginal mucosa in contact with pluronic® F127 hydrogel containing poly(isobutylcyanoacrylate) nanoparticles coated with the mixture chitosan/thiolated chitosan (75/25 wt%) did not reveal any toxicity.

CONCLUSION

This study demonstrated that poly(isobutylcyanoacrylate) nanoparticles coated with chitosan were active against T. vaginalis without adding a drug. Besides their anti-T. vaginalis activity, the formulations are non-toxic towards pig vaginal mucosa.

摘要

目的

本研究报告了一种非传统的治疗策略,该策略基于使用经阴道给药的制剂来治疗由阴道毛滴虫引起的滴虫病,且不添加药物。

方法

这些制剂基于一种热敏性的普朗尼克® F127水凝胶,其中含有用壳聚糖和硫醇化壳聚糖混合物(75/25重量%)包覆的粘膜粘附性聚(异丁基氰基丙烯酸酯)纳米颗粒。纳米颗粒通过异丁基氰基丙烯酸酯的阴离子乳液聚合获得。对这些制剂的抗阴道毛滴虫活性进行了体外评估。

结果

壳聚糖包覆的纳米颗粒在100 μg/mL时显示出强大的抗阴道毛滴虫活性,与硫醇化壳聚糖的比例无关。未包覆壳聚糖的聚(异丁基氰基丙烯酸酯)纳米颗粒以及用作溶液的壳聚糖均未报告有抗阴道毛滴虫活性。这些结果表明,抗阴道毛滴虫活性与聚(异丁基氰基丙烯酸酯)纳米颗粒有关,但仅当它们用壳聚糖包覆时才具有活性。对与含有用壳聚糖/硫醇化壳聚糖混合物(75/25重量%)包覆的聚(异丁基氰基丙烯酸酯)纳米颗粒的普朗尼克® F127水凝胶接触的离体猪阴道粘膜进行组织学分析,未发现任何毒性。

结论

本研究表明,用壳聚糖包覆的聚(异丁基氰基丙烯酸酯)纳米颗粒在不添加药物的情况下对阴道毛滴虫具有活性。除了其抗阴道毛滴虫活性外,这些制剂对猪阴道粘膜无毒。

相似文献

1
Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa.不含药物的壳聚糖包被聚(异丁基氰基丙烯酸酯)纳米颗粒对阴道毛滴虫具有活性,且对猪阴道黏膜无毒。
Pharm Res. 2015 Apr;32(4):1229-36. doi: 10.1007/s11095-014-1528-7. Epub 2014 Oct 16.
2
Surface-dependent endocytosis of poly(isobutylcyanoacrylate) nanoparticles by Trichomonas vaginalis.阴道毛滴虫对聚异丁基氰基丙烯酸酯纳米颗粒的表面依赖性内吞作用。
Int J Pharm. 2018 Sep 5;548(1):276-287. doi: 10.1016/j.ijpharm.2018.07.006. Epub 2018 Jul 3.
3
Gelation and micellization behaviors of pluronic(®) F127 hydrogel containing poly(isobutylcyanoacrylate) nanoparticles specifically designed for mucosal application.含有专为黏膜应用而设计的聚(异丁基氰基丙烯酸酯)纳米颗粒的普朗尼克(®)F127水凝胶的凝胶化和胶束化行为
Colloids Surf B Biointerfaces. 2015 Nov 1;135:669-676. doi: 10.1016/j.colsurfb.2015.08.021. Epub 2015 Aug 22.
4
In situ forming pluronic® F127/chitosan hydrogel limits metronidazole transmucosal absorption.原位形成的普朗尼克® F127/壳聚糖水凝胶限制甲硝唑经黏膜吸收。
Eur J Pharm Biopharm. 2017 Mar;112:143-147. doi: 10.1016/j.ejpb.2016.11.024. Epub 2016 Nov 24.
5
Cell line-dependent cytotoxicity of poly(isobutylcyanoacrylate) nanoparticles coated with chitosan and thiolated chitosan: Insights from cultured human epithelial HeLa, Caco2/TC7 and HT-29/MTX cells.壳聚糖和硫醇化壳聚糖包被的聚(异丁基氰基丙烯酸酯)纳米颗粒的细胞系依赖性细胞毒性:来自培养的人上皮细胞HeLa、Caco2/TC7和HT-29/MTX细胞的见解。
Int J Pharm. 2015 Aug 1;491(1-2):17-20. doi: 10.1016/j.ijpharm.2015.06.001. Epub 2015 Jun 5.
6
The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticles on mucoadhesion due to pluronic F68 addition.壳聚糖包覆聚异丁基氰基丙烯酸酯纳米粒的大小和表面性能的平衡作用对泊洛沙姆 F68 添加引起的粘膜黏附性的影响。
Pharm Res. 2012 Apr;29(4):943-52. doi: 10.1007/s11095-011-0634-z. Epub 2011 Dec 7.
7
Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan.载多西紫杉醇的甲基-β-环糊精/聚异丁基氰基丙烯酸酯纳米粒经巯基化壳聚糖包被后的肠渗透增强作用。
J Control Release. 2012 Sep 28;162(3):568-74. doi: 10.1016/j.jconrel.2012.08.005. Epub 2012 Aug 10.
8
Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles.壳聚糖-聚(异丁基氰基丙烯酸酯)核壳纳米粒子对肠道细胞旁途径的特异性通透性调节
Eur J Pharm Biopharm. 2008 Jun;69(2):436-44. doi: 10.1016/j.ejpb.2007.12.012. Epub 2007 Dec 25.
9
Mucoadhesive properties of low molecular weight chitosan- or glycol chitosan- and corresponding thiomer-coated poly(isobutylcyanoacrylate) core-shell nanoparticles.低分子量壳聚糖或乙二醇壳聚糖以及相应硫醇聚合物包衣的聚(异丁基氰基丙烯酸酯)核壳纳米颗粒的粘膜粘附特性
Eur J Pharm Biopharm. 2017 Aug;117:315-323. doi: 10.1016/j.ejpb.2017.04.020. Epub 2017 Apr 25.
10
Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model.使用具有免疫活性的小鼠模型,超分子壳聚糖微血小板协同增强两性霉素B对白色念珠菌的抗真菌活性。
Pharm Res. 2017 May;34(5):1067-1082. doi: 10.1007/s11095-017-2117-3. Epub 2017 Feb 6.

引用本文的文献

1
In Situ Gelling Behavior and Biopharmaceutical Characterization of Nano-Silver-Loaded Poloxamer Matrices Designed for Nasal Drug Delivery.用于鼻腔给药的载纳米银泊洛沙姆基质的原位凝胶行为及生物药剂学特性
Gels. 2024 Jun 5;10(6):385. doi: 10.3390/gels10060385.
2
The Potential of Chitosan in Nanomedicine: An Overview of the Cytotoxicity of Chitosan Based Nanoparticles.壳聚糖在纳米医学中的潜力:基于壳聚糖的纳米颗粒细胞毒性概述
Front Pharmacol. 2022 May 4;13:880377. doi: 10.3389/fphar.2022.880377. eCollection 2022.
3
An Overview of Mucosa-Associated Protozoa: Challenges in Chemotherapy and Future Perspectives.

本文引用的文献

1
Nanostructured fluids from pluronic® mixtures.由 Pluronic® 混合物构成的纳米结构流体。
Int J Pharm. 2013 Oct 1;454(2):599-610. doi: 10.1016/j.ijpharm.2013.01.043. Epub 2013 Jan 28.
2
Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan.载多西紫杉醇的甲基-β-环糊精/聚异丁基氰基丙烯酸酯纳米粒经巯基化壳聚糖包被后的肠渗透增强作用。
J Control Release. 2012 Sep 28;162(3):568-74. doi: 10.1016/j.jconrel.2012.08.005. Epub 2012 Aug 10.
3
The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticles on mucoadhesion due to pluronic F68 addition.
黏膜相关原生动物概述:化疗的挑战与未来展望。
Front Cell Infect Microbiol. 2022 Apr 25;12:860442. doi: 10.3389/fcimb.2022.860442. eCollection 2022.
4
Emerging Fabrication Strategies of Hydrogels and Its Applications.水凝胶的新兴制备策略及其应用
Gels. 2022 Mar 24;8(4):205. doi: 10.3390/gels8040205.
5
The Expanded Role of Chitosan in Localized Antimicrobial Therapy.壳聚糖在局部抗菌治疗中的扩展作用。
Mar Drugs. 2021 Dec 8;19(12):697. doi: 10.3390/md19120697.
6
A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections.一项评估基于纳米颗粒的非病毒性传播感染疫苗的临床前研究综述。
Front Pharmacol. 2021 Nov 24;12:768461. doi: 10.3389/fphar.2021.768461. eCollection 2021.
7
Antimicrobial Polymer-Based Hydrogels for the Intravaginal Therapies-Engineering Considerations.用于阴道内治疗的抗菌聚合物基水凝胶——工程学考量
Pharmaceutics. 2021 Sep 2;13(9):1393. doi: 10.3390/pharmaceutics13091393.
8
Recent Advances in Polymer-Based Vaginal Drug Delivery Systems.基于聚合物的阴道给药系统的最新进展
Pharmaceutics. 2021 Jun 15;13(6):884. doi: 10.3390/pharmaceutics13060884.
9
In Vitro Antiprotozoal Effects of Nano-chitosan on Plasmodium falciparum, Giardia lamblia and Trichomonas vaginalis.纳米壳聚糖对恶性疟原虫、蓝氏贾第鞭毛虫和阴道毛滴虫的体外抗原生动物作用。
Acta Parasitol. 2021 Mar;66(1):39-52. doi: 10.1007/s11686-020-00255-6. Epub 2020 Jul 14.
10
How the Lack of Chitosan Characterization Precludes Implementation of the Safe-by-Design Concept.壳聚糖特性表征的缺失如何阻碍了“设计即安全”概念的实施。
Front Bioeng Biotechnol. 2020 Mar 10;8:165. doi: 10.3389/fbioe.2020.00165. eCollection 2020.
壳聚糖包覆聚异丁基氰基丙烯酸酯纳米粒的大小和表面性能的平衡作用对泊洛沙姆 F68 添加引起的粘膜黏附性的影响。
Pharm Res. 2012 Apr;29(4):943-52. doi: 10.1007/s11095-011-0634-z. Epub 2011 Dec 7.
4
Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids.不随阴道液稀释而变化的黏附性阴道水凝胶制剂。
Eur J Pharm Biopharm. 2010 Oct;76(2):296-303. doi: 10.1016/j.ejpb.2010.07.004. Epub 2010 Jul 23.
5
A concise analysis of the effect of temperature and propanediol-1, 2 on Pluronic F127 micellization using isothermal titration microcalorimetry.使用等温滴定量热法对温度和1,2 - 丙二醇对普朗尼克F127胶束化作用的简要分析
J Colloid Interface Sci. 2009 Oct 1;338(1):169-76. doi: 10.1016/j.jcis.2009.05.075. Epub 2009 Jun 6.
6
Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.猪离体阴道作为研究黏膜通透性和发病机制的模型。
J Pharm Sci. 2008 Jan;97(1):9-21. doi: 10.1002/jps.21077.
7
Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.壳聚糖及硫醇化壳聚糖-聚(异丁基氰基丙烯酸酯)核壳纳米粒的黏膜黏附机制
Biomaterials. 2007 Apr;28(13):2233-43. doi: 10.1016/j.biomaterials.2007.01.005. Epub 2007 Jan 8.
8
Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.硫醇化壳聚糖包覆丙烯酸纳米颗粒的制备与表征
Int J Pharm. 2006 Jun 19;316(1-2):170-5. doi: 10.1016/j.ijpharm.2006.02.037. Epub 2006 Apr 3.
9
Porcine vaginal mucosa as an in vitro permeability model for human vaginal mucosa.猪阴道黏膜作为人阴道黏膜的体外渗透模型。
Int J Pharm. 2005 Nov 23;305(1-2):105-11. doi: 10.1016/j.ijpharm.2005.09.002. Epub 2005 Oct 13.
10
Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.耐甲硝唑阴道毛滴虫引起的感染的治疗。
Clin Microbiol Rev. 2004 Oct;17(4):783-93, table of contents. doi: 10.1128/CMR.17.4.783-793.2004.